Browsing by Subject "salvage therapy"

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience

Angelopoulou M.K., Vassilakopoulos T.P., Batsis I., Sakellari I., Gkirkas K., Pappa V., Giannoulia P., Apostolidis I., Apostolopoulos C., Roussou P., Panayiotidis P., Dimou M., Kyrtsonis M.-C., Palassopoulou M., Vassilopoulos G., Moschogiannis M., Kalpadakis C., Margaritis D., Spyridonidis A., Michalis E., Anargyrou K., Repousis P., Hatzimichael E., Bousiou Z., Poulakidas E., Grentzelias D., Harhalakis N., Pangalis G.A., Anagnostopoulos A., Tsirigotis P. (2018)

This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ...

Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(−) breast cancer receiving salvage treatment with everolimus/exemestane

Spiliotaki M., Kallergi G., Nikolaou C., Xenidis N., Politaki E., Apostolaki S., Georgoulia N., Koinis F., Tsoukalas N., Hatzidaki D., Kotsakis A., Georgoulias V. (2021)

Purpose: Detection of CTCs represents a poor prognostic factor in patients with early and metastatic breast cancer (mBC) and treatment with everolimus–exemestane (E/E) is an established effective treatment in hormone ...

Editorial: Autoimmune hepatitis - Identifying options for treatment. Authors' reply

Dalekos G.N., Zachou K. (2016)

[No abstract available]

Osteonecrosis of the femoral head: Etiology, imaging and treatment

Malizos, K. N.; Karantanas, A. H.; Varitimidis, S. E.; Dailiana, Z. H.; Bargiotas, K.; Maris, T. (2007)

Osteonecrosis of the femoral head is a disabling clinical entity affecting young adults that usually leads to destruction of the hip joint. A high index of suspicion is necessary for the diagnosis due to the insidious onset ...

Primary extramammary invasive Paget's vulvar disease: What is the standard, what are the challenges and what is the future for radiotherapy?

Tolia M., Tsoukalas N., Sofoudis C., Giaginis C., Spyropoulou D., Kardamakis D., Kouloulias V., Kyrgias G. (2016)

Background: Primary invasive Extramammary Paget's vulvar disease is a rare tumor that is challenging to control. Wide surgical excision represents the standard treatment approach for Primary invasive Extramammary Paget's ...

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: A multicenter national study by the Greek Myeloma Study Group

Katodritou E., Terpos E., Delimpasi S., Kotsopoulou M., Michalis E., Vadikolia C., Kyrtsonis M.-C., Symeonidis A., Giannakoulas N., Vadikolia C., Michael M., Kalpadakis C., Gougopoulou T., Prokopiou C., Kaiafa G., Christoulas D., Gavriatopoulou M., Giannopoulou E., Labropoulou V., Verrou E., Kastritis E., Konstantinidou P., Anagnostopoulos A., Dimopoulos M.A. (2018)

We have studied the efficacy and the prognostic impact of novel agents in 50 primary plasma cell leukemia (pPCL) patients registered in our database. Eighty percent of patients were treated upfront with novel agent-based ...